期刊文献+

维持性透析患者甲状旁腺切除术后低钙血症相关因素分析 被引量:12

The related factors of hypocalcemia after parathyroidectomy in maintenance dialysis patients
下载PDF
导出
摘要 目的探讨维持性透析患者甲状旁腺切除术后发生低钙血症影响因素,为术后防治低钙血症提供临床依据。方法回顾性调查2010年4月~2014年11月45例维持性透析行甲状旁腺切除术患者,收集患者手术前后临床资料,单因素多重线性回归分析确定术后低钙血症的影响因素。结果 45例患者术后均有低钙血症,其中43例需静脉补充钙剂;以静脉补钙时间为因变量,多重回归分析筛选出年龄(β=-0.104,P=0.049)、术前血钙水平(β=-9.923,P=0.018)、术前碱性磷酸酶(β=0.003,P=0.010)和(术后1周碱性磷酸酶―术前碱性磷酸酶)/术前碱性磷酸酶比值(β=2.015,P=0.028)等4个指标为术后低钙血症影响因素。结论年龄、术前血钙水平、术前碱性磷酸酶和碱性磷酸酶比值为甲状旁腺切除术后低钙血症程度影响因素,高危患者需术后严密监测血钙水平并予静脉补钙。 Objective To investigate the related factors of hypocalcemia after parathyroidectomy in maintenance dialysis patients. Methods Forty-five patients treated with parathyroidectomy in the period from April, 2010 to November, 2014 were retrospectively studied. Clinical data of the patients before and after the operation were collected. Multivariate regression was conducted to confirm the factors influencing postoperative hypocalcemia. Results Hypocalcemia presented in all cases (100%) after the operation, and 43 cases of them had to treat with intravenous calcium. Using the length of intravenous calcium as the degree of hypocalcemia, univariate reggression showed that age (β=-0.104, P=-0.049), preoperative serum calcium (β=-9.923, P=0.018), preoperative alkaline phosphate (ALP) (β=0.003, P=0.010), and the ratio of (postoperative ALP-preoperative ALP)/preoperative ALP (β=2.015, P=0.028) were the factors affecting postoperative hypocalcemia. Conelusions Age, preoperative serum calcium, preoperative ALP and the ratio of (postoperative ALP-preoperative ALP)/preoperative ALP are the factors influencing the hypocalcemia after parathyroidectomy.
出处 《中国血液净化》 2017年第2期91-94,共4页 Chinese Journal of Blood Purification
关键词 维持性透析 继发性甲状旁腺功能亢进 甲状旁腺切除术 低钙血症 Maintenance dialysis Hyperparathyroidism Parathyroidectomy Hypocalcemia
  • 相关文献

参考文献2

二级参考文献17

  • 1胡建明,吴宏飞,王笑云,俞香宝,赵奕华,沈霞,刘佳,孙彬,邢昌赢,杨俊伟.肾性甲状旁腺功能亢进症甲状旁腺全切加前臂移植31例临床分析[J].中华内科杂志,2006,45(9):714-716. 被引量:28
  • 2日本透析医学会:透析患者にぉける二次性副甲状腺機能亢進症治療ガイドライン[J].透析会誌,2006,39:1435-1455.
  • 3Kidney Disease:Improving Global Outcomes(K/DIGO)CKD-MBD Work Group:K/DIGO clinical practice guideline forthe diagnosis,evaluation,prevention and treatment of Chronic Kidney Disease-Mineral and Bone Disorder(CKD-MBD)[J].Kidney Int,2009,76(Suppl 113):S1-S130.
  • 4Isakova T,Gutierrez OM,Chang Y,et al.Phosphorus binders and survival on hemodialysis[J].J Am Soc Nephro1,2009,20:388-396.
  • 5Barreto DV,Barreto Fde C,de Carvalho AB,et al.Phosphate binderimpact on bone remodeling and coronary calcification--results from the BRiC study[J].Nephron Clin Pract,2008,110:c273-283.
  • 6Kalantar-Zadeh K,Kuwae N,Regidor DL,et al.Survival predictability of time-varying indicators of bone disease in maintenance hemodialysis patients[J].Kidney Int,2006,70:771-780.
  • 7Richards ML,Wormuth J,Bingener J,et al.Parathyroidectomy in secondary hyperparathyroidism:Is there an optimal operative management[J] ? Surgery,2006,139:174-180.
  • 8Lehmann G,Ott U,Kaemmerer D,et al.Bone histomorphometry and biochemical markers of bone turnover in patients with chronic kidney disease Stages 3-5[J].Clin Nephrol,2008,70:296-305.
  • 9Abe T,Uchita K,Orita H,et al.Effect of beta(2)-microglobulin adsorption column on dialysis-related amyloidosis[J].Kidney Int,2003,64:1522-1528.
  • 10Takei T,Otsubo S,Uchida K,et al.Effects of sevelamer on the progression of vascular calcification in patients on chronic haemodialysis[J].Nephron Clin Pract,2008,108:c278-283.

共引文献50

同被引文献79

引证文献12

二级引证文献47

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部